Literature DB >> 34369809

Developing an International Standard Set of Patient-Reported Outcome Measures for Psychotic Disorders.

Emily McKenzie1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Lucy Matkin1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Luz Sousa Fialho1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Ifeoma Nneka Emelurumonye1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Timea Gintner1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Christiana Ilesanmi1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Beth Jagger1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Shannon Quinney1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Elizabeth Anderson1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Lone Baandrup1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Amrit Kumar Bakhshy1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Alison Brabban1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Tim Coombs1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Christoph U Correll1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Caroline Cupitt1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Anju Devianee Keetharuth1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Dania Nimbe Lima1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Paul McCrone1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Mary Moller1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Cornelis L Mulder1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, David Roe1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Grant Sara1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Farhad Shokraneh1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Jacqueline Sin1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Kristen A Woodberry1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23, Donald Addington1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23.   

Abstract

OBJECTIVE: The objective of this project was to develop a set of patient-reported outcome measures for adolescents and adults who meet criteria for a psychotic disorder.
METHODS: A research team and an international consensus working group, including service users, clinicians, and researchers, worked together in an iterative process by using a modified Delphi consensus technique that included videoconferencing calls, online surveys, and focus groups. The research team conducted systematic literature searches to identify outcomes, outcome measures, and risk adjustment factors. After identifying outcomes important to service users, the consensus working group selected outcome measures, risk adjustment factors, and the final set of outcome measures. International stakeholder groups consisting of >100 professionals and service users reviewed and commented on the final set.
RESULTS: The consensus working group identified four outcome domains: symptoms, recovery, functioning, and treatment. The domains encompassed 14 outcomes of importance to service users. The research team identified 131 measures from the literature. The consensus working group selected nine measures in an outcome set that takes approximately 35 minutes to complete.
CONCLUSIONS: A set of patient-reported outcome measures for use in routine clinical practice was identified. The set is free to service users, is available in at least two languages, and reflects outcomes important to users. Clinicians can use the set to improve clinical decision making, and administrators and researchers can use it to learn from comparing program outcomes.

Entities:  

Keywords:  Outcome and clinical measurement; Psychiatric research; Psychoses; Scales

Mesh:

Year:  2021        PMID: 34369809     DOI: 10.1176/appi.ps.202000888

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  3 in total

Review 1.  Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art.

Authors:  Philip D Harvey; Marta Bosia; Roberto Cavallaro; Oliver D Howes; René S Kahn; Stefan Leucht; Daniel R Müller; Rafael Penadés; Antonio Vita
Journal:  Schizophr Res Cogn       Date:  2022-03-22

2.  Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders.

Authors:  Alessandro Rodolico; Carmen Concerto; Alessia Ciancio; Spyridon Siafis; Laura Fusar-Poli; Carla Benedicta Romano; Elisa Vita Scavo; Antonino Petralia; Salvatore Salomone; Maria Salvina Signorelli; Stefan Leucht; Eugenio Aguglia
Journal:  Brain Sci       Date:  2022-07-07

3.  Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.

Authors:  Lone Baandrup; Peter Allerup; Mette Ø Nielsen; Signe W Düring; Kirsten B Bojesen; Stefan Leucht; Silvana Galderisi; Armida Mucci; Paola Bucci; Celso Arango; Covadonga M Díaz-Caneja; Paola Dazzan; Philip McGuire; Arsime Demjaha; Bjørn H Ebdrup; Wolfgang W Fleischhacker; René S Kahn; Birte Y Glenthøj
Journal:  Acta Psychiatr Scand       Date:  2022-04-22       Impact factor: 7.734

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.